
Australia's Driving Force for Pure Performance in Sport
Deterrence · Detection · Enforcement
Beta-2 agonists are commonly used to treat asthma, however if taken into the bloodstream, they may have anabolic effects. For this reason all beta-2-agonists are prohibited with the exception of those which are inhaled.
Beta-2 agonists are prohibited in and out of competition under the World Anti-Doping Code 2007 Prohibited List (effective from 01/01/07).
Special note: An Abbreviated Therapeutic Use Exemption (ATUE) is required for the use of inhaled beta-2-agonists (formoterol, salbuterol, salmeterol and terbutaline to prevent and /or treat asthma and exercise-induced asthma/broncho-constriction). ATUE forms and further procedural information is on the ASADA website.
This page last updated Tuesday, January 22, 2008
Copyright © 2008, Australian Sports Anti-Doping Authority (ASADA)